NCT06872866View on ClinicalTrials.gov

The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

October 30, 2025

Study Completion Date

December 31, 2025

Conditions
Erectile Dysfunction
Interventions
DRUG

ASP-001.1

Oral liquid suspension of sildenafil

DEVICE

ASP-001.1

Bottle/pump containing ASP-001.1 suspension

Trial Locations (1)

10004

RECRUITING

Aspargo Labs, New York

All Listed Sponsors
lead

Aspargo Labs, Inc

INDUSTRY